Non-opioid Pain Treatment Market: Introduction

  • Pain management is an important component of the medical care. Common types of chronic pain conditions are migraine, lower back pain, osteoarthritis, fibromyalgia, localized musculoskeletal pain, and localized neuropathic pain. While opioids may be appropriate for addressing acute or chronic pain relating to palliative or end-of-life care, and active cancer treatment, other non-opioid pain management options are available to treat chronic pain.
  • Evidences show that non-opioid medications and non-pharmacologic interventions can be effective in treating common types of chronic pain and are considered safer than opioids

Key Drivers and Restraints of Global Non-opioid Pain Treatment Market

  • The global non-opioid pain treatment market is driven by increasing easy and effective medications of non-opioids drugs for pain treatment, and also their less side-effects and low cost for some treatments
  • Opioids have several disadvantages, such as risk of nausea and vomiting, somnolence, androgen deficiency, respiratory depression, constipation, physical dependence, and tolerance. Opioid medications also carry a risk of abuse or addiction by either the patient or non-medical users. For these reasons, consideration of non-opioid strategies for pain management is beneficial. This is fueling the growth of the global non-opoid pain treatment market.
  • Better healthcare facilities and availability of sophisticated and novel treatment options, and increasing research and developmental activities related to non-opoid treatment for pain relief are the major factors propelling the growth of the non-opoid pain treatment market
  • Increasing geriatric population and rising prevalence of diseases, such as arthritis, cancer, epilepsy, dental disorders, etc., leading to chronic pain conditions, such as,  migraine, lower back pain, osteoarthritis, fibromyalgia, localized musculoskeletal pain, and localized neuropathic pain, are fueling the growth of the global non-opioid pain treatment market
  • Preference for alternative therapies and fake products, however, are anticipated to restrain the growth of the global non-opioid pain treatment market

Get a Glimpse of the In-Depth Analysis through our Comprehensive Non-opioid Pain Treatment Market Brochure

Strategies Adopted by Key Players to Offer Attractive Opportunities

  • Companies operating in the global non-opioid pain treatment market focus on addressing the needs of the medical communities and patient population by developing effective and novel products. Leading players are engaging in strategies, such as acquisitions, mergers, and collaborations, along with research and developmental activities to strengthen their position in the global market.
  • In June 2019, Ironwood Pharmaceuticals and Allergan initiated patient dosing in Phase II Clinical Trial of MD-7246 in patients with abdominal pain associated with IBS-D
  • In January 2018, Centrexion Therapeutics raised US$ 67 million and launched Phase 3 program for CNTX-4975 in knee osteoarthritis pain. CNTX-4975, a synthetic, ultra-pure injection of trans-capsaicin for the treatment of chronic pain due to knee osteoarthritis. CNTX-4975 is a highly differentiated, novel, non-opioid therapy designed to be injected directly into the painful joint.
  • In June 2018, Sandoz Canada announced that it had finalized its collaboration agreement with Tilray, a Health Canada licensed producer of medical cannabis, allowing Sandoz Canada to become the first Canadian pharmaceutical company to enter the medical cannabis field
  • Emerging economies present lucrative opportunities in the non-opioid pain treatment market due to increase in patient population and rise in initiatives by governments in the health care sector

North America to Account for Major Share of Global Non-opioid Pain Treatment Market

  • North America is projected to capture leading share of the global non-opioid pain treatment market due to health awareness, rise in patient population, a well-established health care infrastructure, increasing research and developmental activities,  and presence of key players in the region
  • The non-opioid pain treatment market in Asia Pacific is expected to grow at a rapid pace during the forecast period due to rise in patient population, increase in initiatives by governments in the health care sector, surge in incidences of diseases, such as arthritis, cancer, dental disorders, etc., increase in geriatric population, and rise in interest of key players in expanding into the region

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Non-opioid Pain Treatment Market Report

Key Players Operating in Global Non-opioid Pain Treatment Market

Leading players in the global non-opioid pain treatment market are focusing on research and development activities. Companies are adopting various growth strategies, including mergers, acquisitions, product upgrades, product launches & approvals, partnerships, and collaborations. Leading players operating in the global non-opioid pain treatment market are:

  • Allergan
  • Aphria Inc.
  • Bedrocan
  • Cara Therapeutics
  • Centrexion Therapeutics
  • Medical Marijuana, Inc.
  • Medropharm GmbH
  • Panag Pharma Inc.
  • Tilray

Global Non-opioid Pain Treatment Market: Research Scope

Global Non-opioid Pain Treatment Market, by Product

  • Medical Cannabis
  • Menthol-Containing
  • Omega 3 Fatty Acid-Containing
  • Botulinum Toxins
  • Capsaicin-Derived
  • Others

Global Non-opioid Pain Treatment Market, by Therpaeutic Application

  • Orthopaedic & Musculoskeletal Pain
  • Neuropathic Pain
  • Cancer Pain
  • Post-operative Pain
  • Others

Global Non-opioid Pain Treatment Market, by Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Mail Order Pharmacies

Global Non-opioid Pain Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Non Opioid Pain Treatment Market

Pre Book